Central serous chorioretinopathy: Current update on management.

Area of Science:

• Ophthalmology
• Retinal Diseases
• Medical Imaging

Background:

• Central serous chorioretinopathy (CSC) is a common retinopathy, often self-limiting but can lead to persistent visual impairment.
• Advances in multimodal imaging have significantly enhanced understanding of CSC pathophysiology, diagnosis, and management.
• The multifactorial nature of CSC necessitates diverse treatment strategies.

Purpose of the Study:

• To review current multimodal treatment options for Central serous chorioretinopathy (CSC).
• To discuss both conventional and novel therapeutic modalities for CSC.
• To highlight the evolving landscape of CSC management.

Main Methods:

• Literature review of current and emerging treatments for CSC.
• Analysis of multimodal imaging techniques in understanding CSC.
• Evaluation of various therapeutic options, including laser therapies and medical management.

Main Results:

• Multimodal imaging has improved CSC diagnosis and understanding.
• Various treatment options exist, including focal laser, micropulse laser, photodynamic therapy, and transpupillary thermotherapy.
• Medical management for CSC is under active investigation with new drugs.

Conclusions:

• While treatment options for CSC are advancing, a definitive standard of care is yet to be established by randomized clinical trials.
• Multimodal treatment approaches are crucial for managing persistent or recurrent CSC.
• Continued research is needed to refine CSC therapies and establish evidence-based guidelines.